SMARCA2 and breast carcinoma: When missense variants were assessed, three further associations were observed for overall breast cancer (TMEM161A, SIPA1L1, ERCC2), and a further seven were observed for subtypes (RNF175, NCKAP1L, PHAX, SMARCA2, EML5, NTRK3, MED23).